The present invention relates to Polycomb Repressive Complex 2 (PRC2) peptide inhibitors and their use for the treatment of cancer and other conditions associated with aberrant PRC2 methyltransferase activity.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9388213 Polycomb repressive complex 2 (PRC2) inhibitors and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API

US Patent 9388213 Polycomb repressive complex 2 (PRC2) inhibitors and uses thereof

Contents

Patent attributes

Timeline

Further Resources

References

Find more entities like US Patent 9388213 Polycomb repressive complex 2 (PRC2) inhibitors and uses thereof